Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 12201-12210 Newer>

The Motley Fool February 3, 2006 Rich Smith	Foolish Forecast: Hasbro Hits Play Over the past two quarters, the company's inventories have grown almost in lockstep with sales growth -- no danger signs there. Investors, take note.
The Motley Fool February 3, 2006 Rick Aristotle Munarriz	The Chronicles of Disney Yes, Disney's back. The share price may still be trading in the mid-$20s, but the company's prospects have rarely been brighter.
The Motley Fool February 3, 2006 Seth Jayson	Is That Really a Gap Up? Gap's board will have to bring in a management team that can shake things up, but the question here is whether an investment here pays off.
The Motley Fool February 3, 2006 Rick Aristotle Munarriz	A Waterslide Runs Through It Six Flags opens a new upscale resort in a move to stretch its seasonal business. Investors, take note.
The Motley Fool February 3, 2006 Roy Lewis	Deduct Your Worthless Stock Has your investment gone south? Turn it to your tax advantage.
Registered Rep. February 2, 2006 Kristen French	Brokers Learning to Play by New Rules It's no longer business as usual on Wall Street. Starting yesterday, broker/dealers must follow a new SEC rule that requires them to disclose at certain times that they may not be acting in their clients' best interest.
Registered Rep. February 2, 2006 Kristen French	Morgan, BlackRock Talks Reportedly Off Alleged takeover talks between Morgan Stanley and institutional money manager BlackRock have reportedly been called off due to a runup in BlackRock's stock price.
The Motley Fool February 2, 2006 Steven Mallas	Pitney Bowes: Is the Price Right? Given the recent annual results, is the mailing and document concern a buy?
The Motley Fool February 2, 2006 Stephen D. Simpson	Black and White and Red All Over Nothing is going well for Journal Communications. But the publishing and broadcasting businesses have value, and this company does produce free cash flow. Investors, take note.
The Motley Fool February 2, 2006 Brian Gorman	Cambrex in a Crunch The drug manufacturer is suffering despite positive macro trends. For now, investors shouldn't expect much from Cambrex.
<Older 12201-12210 Newer> Return to current articles.